These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15304081)

  • 1. Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatology.
    Prendergast MM; Abramovits W; Boguniewicz M; Lebwohl M; Tokar M; Tong KB
    J Invest Dermatol; 2004 Sep; 123(3):452-4. PubMed ID: 15304081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial conflicts of interest in biomedical research: the need to improve the system.
    Wang AT; Montori VM; Murad MH
    Drug News Perspect; 2010 Nov; 23(9):607-12. PubMed ID: 21152455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scope and impact of financial conflicts of interest in biomedical research: a systematic review.
    Bekelman JE; Li Y; Gross CP
    JAMA; 2003 Jan 22-29; 289(4):454-65. PubMed ID: 12533125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complexities of individual financial conflicts of interest.
    Rubin EH
    Neuropsychopharmacology; 2005 Jan; 30(1):1-6. PubMed ID: 15470374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors.
    Checketts JX; Sims MT; Vassar M
    JAMA Dermatol; 2017 Dec; 153(12):1229-1235. PubMed ID: 29049553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing more open and equitable relationships with industry to improve advancements in clinical research in dermatology.
    Campa M; Ryan C; Menter A
    Br J Dermatol; 2016 Jun; 174(6):1365-9. PubMed ID: 27317287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing bias in industry-sponsored outcomes research.
    Freeman RA
    Med Interface; 1994 Apr; 7(4):130-4. PubMed ID: 10133357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dermatology-industry interface: defining the boundaries.
    Sams WM; Freedberg IM
    J Am Acad Dermatol; 2000 Sep; 43(3):550-4. PubMed ID: 10954674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conflicts of interest in biomedical research--the FASEB guidelines.
    Brockway LM; Furcht LT;
    FASEB J; 2006 Dec; 20(14):2435-8. PubMed ID: 17142792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent and impact of industry sponsorship conflicts of interest in dermatology research.
    Perlis CS; Harwood M; Perlis RH
    J Am Acad Dermatol; 2005 Jun; 52(6):967-71. PubMed ID: 15928613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Disclosure of Potential Conflicts of Interest in Dermatology Patient Advocacy Organizations.
    Li DG; Singer S; Mostaghimi A
    JAMA Dermatol; 2019 Apr; 155(4):460-464. PubMed ID: 30698625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward.
    Prasad V; Rajkumar SV
    Blood Cancer J; 2016 Nov; 6(11):e489. PubMed ID: 27813537
    [No Abstract]   [Full Text] [Related]  

  • 13. Conflict of interest.
    Holmes DR; Firth BG; James A; Winslow R; Hodgson PK; Gamble GL; Popp RL; Harrington RA
    Am Heart J; 2004 Feb; 147(2):228-37. PubMed ID: 14760318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting.
    Williams KM
    Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925
    [No Abstract]   [Full Text] [Related]  

  • 15. Conflicts of interest in dermatology.
    Williams HC; Naldi L; Paul C; Vahlquist A; Schroter S; Jobling R
    Acta Derm Venereol; 2006; 86(6):485-97. PubMed ID: 17106594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conflicts of interest in drug development: the practices of Merck & Co., Inc.
    Hirsch LJ
    Sci Eng Ethics; 2002 Jul; 8(3):429-42. PubMed ID: 12353373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research.
    Jagsi R; Sheets N; Jankovic A; Motomura AR; Amarnath S; Ubel PA
    Cancer; 2009 Jun; 115(12):2783-91. PubMed ID: 19434666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan.
    Murayama A; Ozaki A; Saito H; Sawano T; Shimada Y; Yamamoto K; Suzuki Y; Tanimoto T
    PLoS One; 2020; 15(10):e0239610. PubMed ID: 33048952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
    Tereskerz PM
    Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
    [No Abstract]   [Full Text] [Related]  

  • 20. The changing roles of industry and academia.
    Bauer EA; Cohen DE
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):1033-6. PubMed ID: 22330271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.